Display Settings:

Format

Send to:

Choose Destination
    Am J Ther. 2011 Sep;18(5):340-2. doi: 10.1097/MJT.0b013e3181e70c38.

    A comparative study of intravenous ibandronate and pamindronate in patients with bone metastases from breast or lung cancer: effect on metastatic bone pain.

    Source

    General Hospital of Nafplio, Department of Internal Medicine, Nafplio, Greece. panheras@yahoo.com

    Abstract

    We compared the effects of ibandronate and pamindronate in patients with bone metastases from breast or lung cancer and we found that ibandronate is superior to pamindronate in alleviating pain, improving mobility and quality of life, and reducing bone resorption indices in patients with bone metastases from breast or lung cancer.

    (C) 2011 Lippincott Williams & Wilkins, Inc.

    PMID:
    20634675
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk